-
AptarGroup (ATR) Tops Q4 EPS by 2c; offers guidance
-
AptarGroup (ATR) Declares $0.48 Quarterly Dividend; 1.5% Yield
-
Aptar nasal delivery devices used in CastleVax covid vaccine trial
-
KeyBanc Reiterates Overweight Rating on AptarGroup (ATR)
-
Aptar Digital Health partners with ŌURA to integrate migraine tracking app
-
Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
-
AptarGroup acquires Brazil-based oral dosing packaging firm Sommaplast
-
KeyBanc: White House GLP-1 Deals Boost Growth Potential for Key Suppliers
-
William Blair Downgrades AptarGroup (ATR) to Market Perform
-
AptarGroup (ATR) Tops Q3 EPS by 5c; offers guidance
-
KeyBanc on AptarGroup (ATR): 'Investor Day Highlights Pharma Dominance and Visibility into LT Growth Targets'
-
AptarGroup (ATR) Raises Quarterly Dividend 6.7% to $0.48; 1.4% Yield
-
AptarGroup (ATR) Tops Q2 EPS by 7c; offers guidance
-
Aptar Pharma acquires clinical trial manufacturing capabilities from Mod3 Pharma
-
AptarGroup (ATR) Declares $0.45 Quarterly Dividend; 1.1% Yield
-
AptarGroup (ATR) Tops Q1 EPS by 4c; offers outlook
-
AptarGroup (ATR) Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
-
AptarGroup (ATR) PT Lowered to $205 at Jefferies
-
AptarGroup (ATR) Tops Q4 EPS by 21c, guides below street
-
Raymond James Starts AptarGroup (ATR) at Outperform
-
AptarGroup (ATR) PT Raised to $185 at Baird
-
AptarGroup (ATR) Tops Q3 EPS by 7c, provides guidance
-
AptarGroup (ATR) Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
-
Jefferies Upgrades AptarGroup (ATR) to Buy
-
AptarGroup (ATR) Announces $500M Share Buyback Declares Dividend
-
Baird Reiterates Outperform Rating on AptarGroup (ATR)
-
AptarGroup (ATR) PT Raised to $174 at BofA Securities
-
Aptar's (ATR) N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
-
AptarGroup (ATR) Tops Q2 EPS by 1c, provides guidance
-
AptarGroup (ATR) Raises Quarterly Dividend 9.8% to $0.45; 1.3% Yield

